Bioactive Products
A unique collection of 674 anticancer natural compounds for high throughput screening (HTS) and New anticancer drug research | ||
Catalog No: | B91 | Anticancer Compound Library Screening Details |
Size: | 1mg/well * 674 Compounds 2mg/well * 674 Compounds |
Cat. No. | Information |
CFN98436 | 2,3,4'-Trihydroxy-3',5'-dimethoxypropiophenone Reference standards. |
CFN98446 | Flavokawain A Flavokawain A is an apoptotic inducer and immune- modulator ,it also shows anti-inflammatory, and anti-tumor activities.Flavokawain A can significantly reduce the expression of CDK1-inhibitory kinases, Myt1 and Wee1, and cause cyclin B1 protein accumulation leading to CDK1 activation in T24 cells.Flavokawain A may suppress LPS-induced expression of pro-inflammatory mediators via blockage of NF-κB-AP-1-JNK/p38 MAPK signaling pathways in the murine macrophages. |
CFN98449 | Chelerythrine Chelerythrine is a well-known protein kinase C inhibitor, can inhibit telomerase activity, it also can block the human P2X 7 receptor. Chelerythrine has antimanic, potential antiproliferative and antitumor effects, it has significant cytotoxic effect, independent of p53 and androgen status, on human prostate cancer cell lines. |
CFN98450 | Isoapetalic acid Isoapetalic acid and apetalic acid exhibit cytotoxic activities towards both cancer cell lines(human breast cancer (MCF-7) and human lung carcinoma (A-549) cell lines) and both Gram-positive bacteria(two Gram-positive bacteria, S. aureus and B. subtilis and two Gram-negative bacteria, P. aeruginosa and E. coli.). |
CFN98517 | Docetaxel Docetaxel is an antineoplastic drug by inhibiting microtubule depolymerization, and attenuating of the effects of bcl-2 and bcl-xL gene expression. |